A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain

By Katz Nathaniel   Rauck Richard   Ahdieh Harry   Ma Tina   Gerritsen van der Hoop Roland   Kerwin Rosemary   Podolsky Gilbert  

Current Medical Research and Opinion, Vol. 23, Iss. 1, 2007-01 ,pp. : 117-128

Informa Healthcare

Access to resources Recommend Favorite

Use of TTS Fentanyl as a Single Opioid for Cancer Pain Relief: A Safety and Efficacy Clinical Trial in Patients Naive to Mild or Strong Opioids

By  

Oncology, Vol. 62, Iss. 1, 2002-01 ,pp. : 9-16

Karger

Access to resources Recommend Favorite

Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain

By Clark A.J.   Ahmedzai S.H.   Allan L.G.   Camacho F.   Horbay G.L.A.   Richarz U.   Simpson K.  

Current Medical Research and Opinion, Vol. 20, Iss. 9, 2004-09 ,pp. : 1419-1428

Informa Healthcare

Access to resources Recommend Favorite

A Phase III study to assess the clinical utility of low-dose fentanyl transdermal system in patients with chronic nonmalignant pain

By Otis James   Rothman Margaret  

Current Medical Research and Opinion, Vol. 22, Iss. 8, 2006-08 ,pp. : 1493-1501

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics of a New Fentanyl Tape with a Novel Delivery System of Transdermal Matrix Patches in Patients with Cancer Pain

By  

Oncology, Vol. 86, Iss. 1, 2013-12 ,pp. : 10-15

Karger

Access to resources Recommend Favorite